These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25486200)

  • 1. Induced expression of expanded CGG RNA causes mitochondrial dysfunction in vivo.
    Hukema RK; Buijsen RA; Raske C; Severijnen LA; Nieuwenhuizen-Bakker I; Minneboo M; Maas A; de Crom R; Kros JM; Hagerman PJ; Berman RF; Willemsen R
    Cell Cycle; 2014; 13(16):2600-8. PubMed ID: 25486200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversibility of neuropathology and motor deficits in an inducible mouse model for FXTAS.
    Hukema RK; Buijsen RA; Schonewille M; Raske C; Severijnen LA; Nieuwenhuizen-Bakker I; Verhagen RF; van Dessel L; Maas A; Charlet-Berguerand N; De Zeeuw CI; Hagerman PJ; Berman RF; Willemsen R
    Hum Mol Genet; 2015 Sep; 24(17):4948-57. PubMed ID: 26060190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective rescue of heightened anxiety but not gait ataxia in a premutation 90CGG mouse model of Fragile X-associated tremor/ataxia syndrome.
    Castro H; Kul E; Buijsen RAM; Severijnen LWFM; Willemsen R; Hukema RK; Stork O; Santos M
    Hum Mol Genet; 2017 Jun; 26(11):2133-2145. PubMed ID: 28369393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FMRpolyG alters mitochondrial transcripts level and respiratory chain complex assembly in Fragile X associated tremor/ataxia syndrome [FXTAS].
    Gohel D; Sripada L; Prajapati P; Singh K; Roy M; Kotadia D; Tassone F; Charlet-Berguerand N; Singh R
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1379-1388. PubMed ID: 30771487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astroglial-targeted expression of the fragile X CGG repeat premutation in mice yields RAN translation, motor deficits and possible evidence for cell-to-cell propagation of FXTAS pathology.
    Wenzel HJ; Murray KD; Haify SN; Hunsaker MR; Schwartzer JJ; Kim K; La Spada AR; Sopher BL; Hagerman PJ; Raske C; Severijnen LWFM; Willemsen R; Hukema RK; Berman RF
    Acta Neuropathol Commun; 2019 Feb; 7(1):27. PubMed ID: 30808398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging molecular mechanisms for mitochondrial dysfunctions in FXTAS.
    Gohel D; Berguerand NC; Tassone F; Singh R
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165918. PubMed ID: 32800941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development.
    Botta-Orfila T; Tartaglia GG; Michalon A
    Cerebellum; 2016 Oct; 15(5):599-610. PubMed ID: 27277287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia Syndrome.
    Sellier C; Buijsen RAM; He F; Natla S; Jung L; Tropel P; Gaucherot A; Jacobs H; Meziane H; Vincent A; Champy MF; Sorg T; Pavlovic G; Wattenhofer-Donze M; Birling MC; Oulad-Abdelghani M; Eberling P; Ruffenach F; Joint M; Anheim M; Martinez-Cerdeno V; Tassone F; Willemsen R; Hukema RK; Viville S; Martinat C; Todd PK; Charlet-Berguerand N
    Neuron; 2017 Jan; 93(2):331-347. PubMed ID: 28065649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome.
    Raske C; Hagerman PJ
    J Investig Med; 2009 Dec; 57(8):825-9. PubMed ID: 19794313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Bioenergetics in Primary Dermal Fibroblasts from Adult Carriers of the FMR1 Premutation Before the Onset of the Neurodegenerative Disease Fragile X-Associated Tremor/Ataxia Syndrome.
    Napoli E; Song G; Wong S; Hagerman R; Giulivi C
    Cerebellum; 2016 Oct; 15(5):552-64. PubMed ID: 27089882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CGG repeats in RNA modulate expression of TDP-43 in mouse and fly models of fragile X tremor ataxia syndrome.
    Galloway JN; Shaw C; Yu P; Parghi D; Poidevin M; Jin P; Nelson DL
    Hum Mol Genet; 2014 Nov; 23(22):5906-15. PubMed ID: 24986919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fragile X-associated tremor ataxia syndrome.
    Tassone F; Hagerman R
    Results Probl Cell Differ; 2012; 54():337-57. PubMed ID: 22009361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperine Modulates Protein Mediated Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome through Interacting Expanded CGG Repeat (r(CGG)
    Verma AK; Khan E; Mishra SK; Jain N; Kumar A
    ACS Chem Neurosci; 2019 Aug; 10(8):3778-3788. PubMed ID: 31264835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS).
    Tassone F; Iwahashi C; Hagerman PJ
    RNA Biol; 2004 Jul; 1(2):103-5. PubMed ID: 17179750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome.
    Sellier C; Freyermuth F; Tabet R; Tran T; He F; Ruffenach F; Alunni V; Moine H; Thibault C; Page A; Tassone F; Willemsen R; Disney MD; Hagerman PJ; Todd PK; Charlet-Berguerand N
    Cell Rep; 2013 Mar; 3(3):869-80. PubMed ID: 23478018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic pathways modulate the neuronal toxicity associated with fragile X-associated tremor/ataxia syndrome.
    Kong HE; Lim J; Zhang F; Huang L; Gu Y; Nelson DL; Allen EG; Jin P
    Hum Mol Genet; 2019 Mar; 28(6):980-991. PubMed ID: 30476102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome.
    Brouwer JR; Severijnen E; de Jong FH; Hessl D; Hagerman RJ; Oostra BA; Willemsen R
    Psychoneuroendocrinology; 2008 Jul; 33(6):863-73. PubMed ID: 18472227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic profiling reveals dysregulated lipid metabolism and potential biomarkers associated with the development and progression of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).
    Zafarullah M; Palczewski G; Rivera SM; Hessl DR; Tassone F
    FASEB J; 2020 Dec; 34(12):16676-16692. PubMed ID: 33131090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Motor Dysfunction Modeled in Mice.
    Foote M; Arque G; Berman RF; Santos M
    Cerebellum; 2016 Oct; 15(5):611-22. PubMed ID: 27255703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 suppresses CGG repeat-induced neurotoxicity through interactions with HnRNP A2/B1.
    He F; Krans A; Freibaum BD; Taylor JP; Todd PK
    Hum Mol Genet; 2014 Oct; 23(19):5036-51. PubMed ID: 24920338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.